Latham & Watkins Advises Coalesce Capital in Acquisition of Majority Stake in DAS Health Ventures

Coalesce Capital, a private equity firm focused on investing in human capital-driven and technology-enabled services companies, has announced it has acquired a majority stake in DAS Health Ventures, a leading provider of healthcare IT and business solutions. Sheridan Capital Partners, which invested in DAS Health in 2021, will retain a minority ownership position and continue to support the company’s growth.

Latham & Watkins LLP represents Coalesce Capital in the transaction with a corporate deal team led by Boston partners Ryan McCarthy and Elizabeth Slawsby, with associates Dante Spurlock, Brian Wolgast, and Daniel Barks. Advice was also provided on debt finance matters by Boston partner Susan Parker, with associate Jake Hummer; on tax matters by Washington, D.C. partner Andrea Ramezan-Jackson, with associate Christina McLeod; on benefits matters by Boston partner Josh Friedman, with associate Rebecca Fishbein; on labor matters by Washington, D.C. partner Sandra Benjamin, with associate Elizabeth Duncan; on IP matters by Boston associates Debbie Hinck and Victoria Allen; on data privacy matters by Bay Area partner Heather Deixler, with associates Zac Alpert and Ryleigh Chen; and on insurance matters by Los Angeles partner Harrison White, with associate Enrique Covarrubias.